Correlation Between Sellas Life and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Sellas Life and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sellas Life and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sellas Life Sciences and Inhibrx, you can compare the effects of market volatilities on Sellas Life and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sellas Life with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sellas Life and Inhibrx.
Diversification Opportunities for Sellas Life and Inhibrx
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Sellas and Inhibrx is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Sellas Life Sciences and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Sellas Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sellas Life Sciences are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Sellas Life i.e., Sellas Life and Inhibrx go up and down completely randomly.
Pair Corralation between Sellas Life and Inhibrx
Considering the 90-day investment horizon Sellas Life Sciences is expected to generate 2.22 times more return on investment than Inhibrx. However, Sellas Life is 2.22 times more volatile than Inhibrx. It trades about 0.06 of its potential returns per unit of risk. Inhibrx is currently generating about -0.02 per unit of risk. If you would invest 99.00 in Sellas Life Sciences on December 28, 2024 and sell it today you would earn a total of 12.00 from holding Sellas Life Sciences or generate 12.12% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Sellas Life Sciences vs. Inhibrx
Performance |
Timeline |
Sellas Life Sciences |
Inhibrx |
Sellas Life and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sellas Life and Inhibrx
The main advantage of trading using opposite Sellas Life and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sellas Life position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Sellas Life vs. NLS Pharmaceutics AG | Sellas Life vs. Mereo BioPharma Group | Sellas Life vs. Day One Biopharmaceuticals | Sellas Life vs. Reviva Pharmaceuticals Holdings |
Inhibrx vs. Day One Biopharmaceuticals | Inhibrx vs. Mirum Pharmaceuticals | Inhibrx vs. Rocket Pharmaceuticals | Inhibrx vs. Avidity Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |